Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-23

FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for nicardipine hydrochloride (Hikma Pharmaceuticals USA Inc.), resulting in labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine hydrochloride (Nicardipine)

Snippet

SUPPL AP for NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)